Skip to main content

Oxford Cannabinoid Technologies

Oxford, United Kingdom

OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.

$714K raised
Feb 2024
Post-IPO Debt

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oxford Cannabinoid Technologies

How much funding has Oxford Cannabinoid Technologies raised?
Oxford Cannabinoid Technologies has raised $714K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2024.
Who are Oxford Cannabinoid Technologies's investors?
Oxford Cannabinoid Technologies's investors include Casa Verde Capital, Julien Codorniou, Kingsley Capital Partners, Neil Mahapatra, Cantheon Capital.
Where is Oxford Cannabinoid Technologies headquartered?
Oxford Cannabinoid Technologies is headquartered in Oxford, United Kingdom.
What does Oxford Cannabinoid Technologies do?
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
What stage is Oxford Cannabinoid Technologies at?
Oxford Cannabinoid Technologies is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Oxford Cannabinoid Technologies — Funding & Investors." VCBacked, February 2, 2024, https://www.vcbacked.co/company/oxford-cannabinoid-technologies. Accessed July 2, 2026.
APA
VCBacked. (2024). Oxford Cannabinoid Technologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oxford-cannabinoid-technologies
Wikipedia (cite web)
{{cite web |title=Oxford Cannabinoid Technologies — Funding & Investors |url=https://www.vcbacked.co/company/oxford-cannabinoid-technologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .